http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20070015377-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4180fc57a693864e2ce2dbfd64a9278
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C303-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-52
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4355
filingDate 2005-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfa8c3a234511dbe83818b732ad5a7ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0dfb2f53a7f21e7761b70b779745dce8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd7b5c26119310459d2b5aae8444c3e4
publicationDate 2007-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20070015377-A
titleOfInvention Method for preparing tryptase inhibitor
abstract The present invention relates to a process for preparing compounds of formula (I) and salts thereof used as tryptase inhibitors, intermediates used in the preparation of these compounds, processes for preparing such intermediates and the use of these intermediates in such compounds. will be.n n n Formula In n n n n n n n In Formula I above,n n n R 1 and R 2 are as defined in the specification.
priorityDate 2004-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467547056
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467228529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467228846
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467228844

Total number of triples: 34.